REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 130.00
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 15.00 (11.538%)
Open: 137.50
High: 140.00
Low: 137.50
Prev. Close: 137.50
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options and deferred bonus award

1 Aug 2022 07:00

RNS Number : 3408U
Manolete Partners PLC
01 August 2022
 

1 August 2022

 

Manolete Partners plc

("Manolete" or the "Company")

 

 

Grant of Share Options and deferred bonus award

 

Manolete, a leading UK insolvency litigation financing company announces that on 29 July 2022, it granted nominal cost share options over ordinary shares of 0.4p each in the Company to its executive directors as set out in the table below.

 

Director

Award type

Number of shares subject to option

Steven Cooklin

Performance share award

163,797

Mark Tavener

Performance share award

64,234

Mark Tavener

Deferred bonus award

16,058

Philomena Halton

Performance share award

120,269

 

The options were granted under the Company's share option plan.

 

The performance share awards will ordinarily vest on the third anniversary of their grant subject to the grantee's continued service and the satisfaction of performance conditions based on (with equal weighting) (i) earnings per share for the Company's financial year ending 31 March 2025; (ii) average share price over the three months preceding the third anniversary of the grant of the options; and (iii) the group's strategic objectives for the period of three financial years ending 31 March 2025. Sliding scale performance targets apply in respect of the earnings per share and average share price elements, with 25% of the relevant portion of each option vesting for threshold performance, rising on a straight-line basis for full vesting of the relevant portion of each option for stretch performance or better. The extent of vesting of the strategic element will be dependent on the remuneration committee of the Board's assessment of related performance.

 

The deferred bonus award will ordinarily vest on the first anniversary of its grant subject to the grantee's continued service. The deferred bonus award relates to a deferred bonus awarded in shares for the Company's financial year ended 31 March 2022 and sits alongside the annual cash bonus disclosed in the latest report and accounts for the same year.

 

Each option has a per share exercise price equal to the nominal value of a share.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. The announcement, including the notification(s) below, is made in accordance with the requirements of the Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Steven Cooklin

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Manolete Partners plc

b)

LEI

213800R2X9V3KWCC4H47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.4p

Identification code

GB00BYWQCY12

b)

Nature of the transaction

Options over ordinary shares with an exercise price per ordinary share equal to the nominal value of an ordinary share

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

163,797

d)

Aggregated information:

·Aggregated volume

·Price

See 4 (c) above

e)

Date of the transaction

29 July 2022

 

f)

Place of the transaction

Outside of a trading venue 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Tavener

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Manolete Partners plc

b)

LEI

213800R2X9V3KWCC4H47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.4p

Identification code

GB00BYWQCY12

b)

Nature of the transaction

Options over ordinary shares with an exercise price per ordinary share equal to the nominal value of an ordinary share

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

64,234

Nil

16,058

d)

Aggregated information:

·Aggregated volume

·Price

See 4 (c) above

· 80,292

e)

Date of the transaction

29 July 2022

 

f)

Place of the transaction

Outside of a trading venue 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Philomena Halton

2.

Reason for the Notification

a)

Position/status

Managing Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Manolete Partners plc

b)

LEI

213800R2X9V3KWCC4H47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.4p

Identification code

GB00BYWQCY12

b)

Nature of the transaction

Options over ordinary shares with an exercise price per ordinary share equal to the nominal value of an ordinary share

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

120,269

d)

Aggregated information:

·Aggregated volume

·Price

See 4 (c) above

e)

Date of the transaction

29 July 2022

 

f)

Place of the transaction

Outside of a trading venue 

 

For further information, please contact:

Manolete Partners Plc

Via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

Peel Hunt (NOMAD and Broker)

+44 (0)20 7418 8900

Paul Shackleton

James Britton

Instinctif Partners (Financial PR)

+44 (0)78 3767 4600

Tim Linacre

manolete@instinctif.com

Victoria Hayns

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFDDFIAFIF
Date   Source Headline
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results
3rd Nov 20217:00 amRNSNotice of Half Year Results
6th Oct 20217:00 amRNSTrading Update
1st Oct 20212:52 pmRNSDirector/PDMR Dealings
22nd Sep 20219:57 amRNSResult of AGM
21st Sep 20217:00 amRNSAGM Statement
9th Jul 20214:30 pmRNSPosting of Annual Report and Notice of AGM
25th Jun 20217:00 amRNSManolete Partners ranked in Band 1 by Chambers
24th Jun 202112:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20217:00 amRNSFull Year Results
23rd Jun 20217:00 amRNSAppointment of Chairman Designate
14th Jun 202110:29 amRNSNotice of Full Year Results
1st Mar 202112:45 pmRNSTR-1: Notification of Major Holdings
23rd Feb 20217:00 amRNSUpdated Investor Presentation
22nd Feb 20217:00 amRNSInvestor Presentation
10th Feb 202111:28 amRNSTR-1: Notification of Major Holdings
10th Feb 20217:00 amRNSDirector/PDMR Dealings
9th Feb 20217:00 amRNSDirector/PDMR Dealings
1st Feb 20217:21 amRNSDirector/PDMR Dealings
29th Jan 20217:00 amRNSDirector/PDMR Dealings
28th Jan 20211:09 pmRNSTR-1: Notification of Major Holdings
28th Jan 202111:24 amRNSTR-1: Notification of Major Holdings
27th Jan 20212:42 pmRNSTR-1: Notification of Major Holdings
26th Jan 20214:40 pmRNSSecond Price Monitoring Extn
26th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20212:47 pmRNSQ3 Trading Update
5th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Dec 20202:02 pmRNSTR-1: Notification of Major Holdings
18th Nov 202010:29 amRNSLarge Case Update
12th Nov 20207:00 amRNSFurther Significant Case Completion
10th Nov 20207:00 amRNSHalf Year Results
3rd Nov 20202:52 pmRNSNotice of Half Year Results
1st Oct 20207:00 amRNSGrant of Share Options
22nd Sep 202011:51 amRNSResult of AGM
17th Sep 20207:00 amRNSDirector/PDMR Shareholding
15th Sep 20204:23 pmRNSTrading Update - Significant Case Completion
24th Jul 20205:20 pmRNSNotification of Major Holdings
15th Jul 20204:02 pmRNSNotification of Major Holdings
14th Jul 20207:00 amRNSResponse to Article Published by ShareProphets
13th Jul 20204:41 pmRNSSecond Price Monitoring Extn
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:46 pmRNSPosting of Annual Report and Notice of AGM
13th Jul 20209:05 amRNSSecond Price Monitoring Extn
13th Jul 20209:00 amRNSPrice Monitoring Extension
3rd Jul 20207:05 amRNSAppointment of Joint Broker
3rd Jul 20207:00 amRNSFull Year Results
30th Jun 20203:56 pmRNSNotice of Full Year Results
29th Jun 202011:08 amRNSUpdate on Judgment
22nd Jun 20207:00 amRNSChange of Date for Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.